Dermatologic & Skin Therapeutics: World Markets & Advances

• 1.1 Scope and Objectives of the Report
• 1.2 Methodology
• 1.3 A Look at Dermatologic/Skin Therapeutics

2 Overview

• 2.1 Definition and Types of Dermatologic Diseases
• 2.1.1 Definition
• 2.1.2 Disease/Disorder Types Covered
• 2.2 Pathology of Dermatologic Diseases
• 2.3 Prevalence and Demographics
• 2.4 Issues and Trends in Dermatologic Diseases
• 2.4.1 Health and Economic Consequences of Dermatologic Diseases
• 2.4.2 Regulatory and Legislative Actions for Dermatologic Diseases
• 2.4.3 Grassroots/Public Awareness Campaigns for Dermatologic Diseases
• 2.4.4 Industry Actions for Dermatologic Diseases

3 Psoriasis

• 3.1 Overview
• 3.1.1 Plaque-Type Psoriasis
• 3.1.2 Guttate Psoriasis
• 3.1.3 Pustular Psoriasis
• 3.1.4 Erythrodermic Psoriasis
• 3.1.5 Nail Psoriasis
• 3.1.6 Psoriatic Arthritis
• 3.2 Risk Factors
• 3.3 Incidence and Mortality
• 3.4 Treatments for Psoriasis
• 3.4.1 Calcipotriol
• 3.4.2 Corticosteroids
• 3.4.3 Other Topical Agents
• 3.4.4 Systemic Drugs
• 3.4.5 Phototherapy
• 3.5 Research and Development
• 3.6 Market Analysis for Psoriasis Drugs
• 3.6.1 Total World Market Size and Growth
• 3.6.2 U.S. Market Size and Growth
• 3.6.3 Western European Market Size and Growth
• 3.6.4 Japanese Market Size and Growth
• 3.6.5 Rest of World Market Size and Growth
• 3.7 Competitor Analysis

4 Scleroderma

• 4.1 Overview
• 4.1.1 Localized Scleroderma
• 4.1.2 Systemic Scleroderma
• 4.2 Risk Factors
• 4.3 Incidence and Mortality
• 4.4 Treatments for Scleroderma
• 4.4.1 ACE Inhibitors
• 4.4.2 DMARDs
• 4.4.3 Calcium Channel Blockers
• 4.4.4 Other Medications
• 4.5 Research and Development
• 4.6 Market Analysis for Scleroderma Drugs
• 4.6.1 Total World Market Size and Growth
• 4.6.2 U.S. Market Size and Growth
• 4.6.3 Western European Market Size and Growth
• 4.6.4 Japanese Market Size and Growth
• 4.6.5 Rest of World Market Size and Growth
• 4.7 Competitor Analysis

5 Eczema/Atopic Dermatitis

• 5.1 Overview
• 5.2 Risk Factors
• 5.3 Incidence and Mortality
• 5.4 Treatments for Eczema/Atopic Dermatitis
• 5.4.1 Topical Steroids
• 5.4.2 Oral Steroids
• 5.4.3 Immunomodulators
• 5.4.4 Other Medications
• 5.4.5 Light Therapy
• 5.5 Research and Development
• 5.6 Market Analysis for Atopic Dermatitis Drugs
• 5.6.1 Total World Market Size and Growth
• 5.6.2 U.S. Market Size and Growth
• 5.6.3 Western European Market Size and Growth
• 5.6.4 Japanese Market Size and Growth
• 5.6.5 Rest of World Market Size and Growth
• 5.7 Competitor Analysis

6 Acne

• 6.1 Overview
• 6.2 Risk Factors
• 6.3 Incidence and Mortality
• 6.4 Treatments for Acne
• 6.4.1 Accutane
• 6.4.2 Retinoids
• 6.4.3 Antibiotics
• 6.4.4 OTC Treatments
• 6.4.5 Oral Contraceptives
• 6.5 Research and Development
• 6.6 Market Analysis for Acne Drugs
• 6.6.1 Total World Market Size and Growth
• 6.6.2 U.S. Market Size and Growth
• 6.6.3 Western European Market Size and Growth
• 6.6.4 Japanese Market Size and Growth
• 6.6.5 Rest of World Market Size and Growth
• 6.7 Competitor Analysis

7 Skin Cancer

• 7.1 Overview
• 7.1.1 Melanoma
• 7.1.2 Basal Cell Carcinoma
• 7.1.3 Squamous Cell Carcinoma
• 7.1.4 Actinic Keratoses
• 7.2 Risk Factors
• 7.3 Incidence and Mortality
• 7.4 Treatments for Skin Cancer
• 7.4.1 Topical Antimetabolites
• 7.4.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
• 7.4.3 Chemotherapy
• 7.4.4 Immunotherapy
• 7.4.5 Surgery and Cryosurgery
• 7.4.6 Radiation
• 7.5 Research and Development
• 7.6 Market Analysis for Skin Cancer Drugs
• 7.6.1 Total World Market Size and Growth
• 7.6.2 U.S. Market Size and Growth
• 7.6.3 Western European Market Size and Growth
• 7.6.4 Japanese Market Size and Growth
• 7.6.5 Rest of World Market Size and Growth
• 7.7 Competitor Analysis

8 Total Market Summary

• 8.1 Total Global Market by Disease/Condition
• 8.2 Total Global Market by Geographic Region
• 8.3 Competitive Analysis

9 Company Briefs

• 9.1 Allergan, Inc.
• 9.2 AstraZeneca
• 9.3 Bayer AG
• 9.4 Bristol-Myers Squibb Co.
• 9.5 Dermik Laboratories, Inc.
• 9.6 Fujisawa Japan
• 9.7 Galderma Laboratories L.P.
• 9.8 GlaxoSmithKline
• 9.9 Merck & Co., Inc.
• 9.10 Novartis AG
• 9.11 Ortho-McNeil Pharmaceutical, Inc.
• 9.12 Pfizer, Inc.
• 9.13 Pharmacia Corp.
• 9.14 Hoffmann-La Roche, Inc.
• 9.15 Schering-Plough Corp.